Laparoscopic Resection After Neoadjuvant Chemotherapy for Distal Gastric Tumors
In this study, an open-label, single cente r, phase 2 randomized clinical trial with a noninferiority design, the authors assessed outcomes at 3 years. All patients received neoadjuvant therapy of oxaliplatin and capecitabine before their operation. Li and colleagues reported significantly lower postoperative complication rates, less postope rative pain, and better adherence to and completion of adjuvant therapy among trial participants.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Eloxatin | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | Laparoscopy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pain | Sports Medicine | Study | Xeloda